HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - Can patients respond to a second line BCMA treatment? (2026 Updated)

Posted by
HealthTree Logo HealthTree
• February 27, 2026

Description

This video explains whether patients can respond to a second line BCMA treatment.

On this video

Healthtree contact Mohamad Mohty, Specialist

Mohamad Mohty, Specialist

Hôpital Saint-antoine

Healthtree contact Natalie Callander, MD, Specialist

Natalie Callander, MD, Specialist

Carbone Cancer Center -(UW Health)

Related Content

  • Video Preventing Myeloma Relapse Using a Response Adaptive Dosing Approach | Erin Meermeier, PhD
  • Video Relapsed & Refractory Myeloma: What’s Changing and What’s Next Rahul Banerjee, MD, FACP
  • Video LimiTEC: Limited-Duration Teclistamab Results | Beatrice Razzo, MD & Cindy Chmielewski
  • Video Promising Results with Elranatamab + Iberdomide from MagnetisMM-30| Attaya Suvannasankha, MD
  • Video Etentamig in patients with relapsed refractory amyloidosis | Rajshekhar Chakraborty, MD
  • Video Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD